scroll to begin
TRANSFORMING
HEALTHCARE througH
DEEP LEARNING

PREDICTIVE AI

WILL REVOLUTIONIZE

PATIENT MONITORING

Our predictive patient monitoring software allows healthcare providers to respond to life-threatening medical events before they occur.

Using cutting-edge machine learning techniques employed at CERN's Large Hadron Collider, we identify subtle changes preceding patient deterioration that are invisible to both physicians and standard patient monitoring software, transforming the patient monitoring paradigm from reactive to predictive.

Our first patented technology—built using the largest database of its kind—identifies patients at imminent risk of sudden cardiac arrest, allowing doctors and nurses to take preventive actions.

The American Heart Association recommends early intervention as the centerpiece of its guidelines on improving cardiac arrest care, based on research showing that early action saves lives and improves neurological outcomes among survivors.  Our technology offers new hope for the 299,000 patients who experience cardiac arrest in US hospitals each year—of whom only 25% survive—and for the 6 million people around the world who die from sudden cardiac arrest annually.

With funding from leading mission-driven organizations (Wellcome Trust, Innovate UK, EU Data Pitch, Prototron) and investors (Tera Ventures, InHealth Ventures, Entrepreneur First, AI Seed), we are bringing our sudden cardiac arrest prediction technology to patients and developing our next generation of predictive technologies.

Team

JOSH OPPENHEIMER,
MD, MBA
Co-Founder &
 CEO


Josh holds an MD from Mount Sinai, an MBA from Cambridge, and a degree in Health Policy from Princeton. Josh was a chief resident at George Washington University Hospital and is a practicing emergency medicine physician.
MAREK SIRENDI,
PhD
Co-Founder &
CTO


Marek holds a PhD in Physics from Cambridge. He previously developed deep learning models at CERN's Large Hadron Collider to precisely measure the W and Higgs bosons.
MAREK REI,
PhD
Co-Founder &
Chief Scientific Officer


Marek holds a PhD from Cambridge. Marek is a visiting lecturer at Cambridge and a lecturer at Imperial College London. He previously developed predictive deep learning models at SwiftKey, which was acquired by Microsoft.
WEIJIA LI,
MBA
COO


Weijia holds an MBA from Cambridge. She previously worked in management consulting at Capco and operations at Origami Energy.
LAURA KARINDI,
MSc
Chief Strategy Officer

Laura holds an MSc in Biomedical Engineering and Medical Physics. She previously worked as a manager and biomedical engineer in hospitals.
BUNSI KESHAV,
MSc
Head of Partnerships

Bunsi holds an MSc in Clinical Engineering from King's College London. She previously worked in clinical engineering at the NHS.
DIOGO SANTOS,
PhD
Senior Data Scientist

Diogo holds a PhD from the Institute of Cardiovascular Science at University College London.
SCOTT VINAY,
PhD
Data Scientist

Scott holds a PhD in Quantum Cryptography from the University of Sheffield
ELIZABETH JENNINGS
Advisor, US

Elizabeth brings vast experience advising medical technology and life science start-ups and investors. She is the Founder and Principle of Venture Atlas Labs.
JACK LEWIN, MD
Advisor, US

Jack brings decades of experience in healthcare innovation, having previously served as CEO of both the American College of Cardiology and the Cardiovascular Research Foundation. He is the President of the National Coalition on Health Care.
ENO-MARTIN LOTMAN, MD
Advisor, EU

Eno-Martin is a cardiologist at North Estonia Medical Centre, Estonia's largest hospital.
The future is already here -
it's just not evenly distributed.

- William Gibson

LET’S TALK

We'd like to hear from you! Contact us here.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(